Healing from injury requires the activation and proliferation of stem cells for tissue repair. Previous studies have demonstrated that bone marrow is a central pool of stem cells. The present study aimed to investigate the route undertaken by bone marrow mononuclear cells (BMMCs) following BMMC transplantation by masseter injection in a rat model of midpalatal expansion. The rats were divided into five groups according to the types of midpalatal expansion, incision and BMMC transplantation. Samples of midpalatal bone from the rats in each group were used for histological and immunohistochemical assessments to track and evaluate the differential potentials of the transplanted BMMCs in the masseter muscle and midpalatal bone. Bromodeoxyuridine was used as a BMMC tracing label, and M-cadherin was used to detect muscle satellite cells. The BMMCs injected into the masseter were observed, not only in the masseter, but also in the blood vessels and oral mucosa, and enveloped the midpalatal bone. A number of the BMMCs transformed into osteoblasts at the boundary of the neuromuscular bundle, and were embedded in the newly formed bone during midpalatal bone regeneration. The results of the present study suggested that BMMCs entered the circulation and migrated from muscle to the bone tissue, where they were involved in bone repair. Therefore, BMMCs may prove useful in the treatment of various types of cancer.
Introduction
Skeletal injury is one of the most prevalent problems observed clinically, which impairs the daily activities of the patients (1) . Bone repair is regulated by a highly coordinated series of molecular, cellular and tissue events; and the recruitment, proliferation and accumulation of stem cells at the site of injury are the essential aspects of the repair process (2) . Immature stem cells differentiate into dynamic osteoblasts in order to restore bone tissues (3) . Bone injury healing also critically depends on the growth of blood vessels, not only for nutrient supply, but also for the influx of osteoblasts (4, 5) . Previous evidence has indicated that physiological bone remodeling occurs in close proximity to blood vessels, and these vessels carry perivascular stem cells, which then differentiate into osteoblasts (5) .
The marrow stroma is a complex tissue, which contains cells that are required for the lineage commitment of hematopoietic and non-hematopoietic cells and can differentiate into various types of mesenchymal and non-mesenchymal cell (6) . Bone marrow mononuclear cells (BMMCs) include several types of marrow stem cells, including hematopoietic stem cells, mesenchymal stem cells, endothelial progenitor cells and other precursor stem cells (7) . Following trauma, these cells secrete cell growth factors, which promote tissue differentiation of the transplanted BMMCs, leading to repair of the injured organs and restoration of organ function (8) (9) (10) . In preclinical and clinical trials, bone marrow-derived stem cells have been successfully applied for bone and cartilage regeneration following osteoporotic fracture and arthritis (11, 12) .
Although studies have suggested that homing of native stem cells to injured tissue and their subsequent involvement in the regenerative process is a natural healing response (13) (14) (15) , the mechanism underlying the function of these stem cells in bone repair remains to be elucidated. In the present study, a rat model of midpalatal incision and expansion was constructed and used to investigate the mechanism underlying the movement of transplanted BMMCs into the circulation and how they become stationed at the injury site for bone repair. The results may provide further understanding of bone injury healing by stem cells.
Materials and methods

Animals and grouping.
A total of 15 male, 8-week-old Sprague-Dawley rats (Vital River Laboratory Animal Technology Co., Ltd., Beijing, China), with a mean weight of 208.36±7.32 g, were used in the present study. The rats were housed in an International Standards Organization (ISO) class 7 room with 50% relative humidity. The rats underwent a reversed 12:12 h light/dark cycle and were maintained at 22-25˚C in an atmosphere containing 5% CO 2 . They were given 5 g feedstuff and 11 ml per 100 g body weight of water daily. All groups of animals were housed together with a different marker. All rats were treated according to the ethical regulations defined by the Ethics Committee of Capital Medical University (Beijing, China).
The rats were divided into five groups, with three rats in each group, as follows: Control group (Inc), in which the midpalatal suture was sectioned without expansion or BMMC transplantation; expansion group (Exp), in which the rats underwent midpalatal expansion for 2 weeks with incision, but no BMMC transplantation; expansion and transplantation group (EaT), in which the rats underwent midpalatal expansion for 2 weeks with incision and BMMC transplantation; expansion and relapse group (ExR), in which the rats underwent midpalatal expansion for 2 weeks with incision, but no BMMC transplantation, followed by removal of the expansion appliance (0.45 mm stainless steel AJ Wilcock Australian Wire; AJ Wilcock PTY., Ltd., Whittlesea, Australia) and observation of palatal changes during relapse; expansion/transplantation/relapse group (EtR), in which the rats underwent midpalatal expansion for 2 weeks with incision and BMMC transplantation, prior to removal of the expansion appliance and sacrifice of the rats 2 weeks later in order to observe palatal changes during relapse. The rats were sacrificed by cervical dislocation. None of the groups of rats experienced a significant loss of body weight during the fed period. At the beginning of rapid suture expansion, food intake was disturbed, however, the body weight of the rats recovered afterwards. Samples of midpalatal tissues were obtained from these rats in each group, which were used for further histological and immunohistochemical analyses.
Expansion of the midpalatal suture. The rats were subjected to midpalatal expansion, as described in a previous study (16) . The distal ends of the expansion appliances were placed into the inter-proximate space between the second and third molars, and the appliances were activated through the ends of the compression helices to exert an initial expansion force of 150 g. A 1.5 cm anteroposterior mid-sagittal incision was made following appliance placement. The expansion appliances were activated once every other day (150 g each time) in order to obtain the effects of midpalatal expansion. The duration of midpalatal expansion was two weeks.
BMMC culture and transplantation. Bone marrow aspirate is considered to be the most accessible and enriched source of mesenchymal stem cells due to the efficient isolation of multi-potential cells from this tissue (17) . Mouse BMMCs were harvested and cultured using a previously described method with modifications (18) . Briefly, a 2-month-old male BALB/C mouse (Vital River Laboratory Animal Technology Co., Ltd.) was chosen as the donor of BMMCs. The mouse was housed in an ISO class 7 room with 50% relative humidity. The mouse underwent a reversed 12:12 h light/dark cycle and was maintained at 22-25˚C in an atmosphere containing 5% CO 2 , and was given 4 g feedstuff and 5 ml per 100 g body weight of water daily. BMMCs were obtained by flushing the femur of the mouse with Dulbecco's modified Eagle's medium (DMEM)/F12 (Invitrogen; Thermo Fisher Scientific, Inc., Waltham, MA, USA), and centrifuged at 400 x g for 10 min to remove adipose tissue. The cell pellet was suspended in 5 ml chilled Hanks' balanced salt solution and layered over 8 ml Percoll solution (1.073 g/ml) (both GE Healthcare Life Sciences, Chalfont, UK). Following centrifugation at 800 x g for 30 min, the mononuclear cell layer was removed from the interface, suspended in DMEM/F12 supplemented with 20% fetal bovine serum, 50 mg/ml ascorbic acid, and 100 mg/ml penicillin-streptomycin (Gibco; Thermo Fisher Scientific, Inc.), and incubated at 37˚C in a humidified atmosphere containing 5% CO 2 . The cells reached 80% confluence in 8-10 days, and were then suspended using trypsin-ethylenediaminetetraacetic acid, prior to passage for expansion. The cells from passage four were numerous and of suitable shape, and were used for subsequent cell transplantation.
To identify and track BMMCs following midpalatal transplantation, the cells were labeled with bromodeoxyuridine (BrdU; Sigma-Aldrich, St. Louis, MO, USA). The expanded and labeled BMMCs (1x10 6 cells/ml; 0.5 ml) suspended in sterile medium were intra-orally injected into the left masseter area opposite the first molar in the EaT and EtR groups 2 days following the second activation, and the expansion appliances were maintained in place for two weeks. Physiological saline solution (5 mg/kg; 0.9% sodium chloride) was injected, in the same manner, in the rats of the Exp and ExR groups.
Observation of histological changes in morphology.
Once the rats had been sacrificed, the mandible and facial skin were removed. The maxillary tissue was fixed in 10% formalin solution [New England Biolabs (Beijing) Ltd., Beijing, China] for 48 h, and was then demineralized in 10% EDTA (pH 7.2; Sinopharm Chemical Reagent Co., Ltd., Beijing, China) for 6-8 weeks until the bone tissue had softened. Subsequently, samples of the midpalatal bone between the first and third molars of the rats were isolated and embedded with paraffin 
Tracking and evaluation of the differential potential of transplanted BMMCs in the masseter and midpalatal bone.
The transplanted BMMCs labeled with BrdU were identified and tracked using immunofluorescence staining with mouse monoclonal anti-BrdU primary antibody (1:100; cat. no. B8434; Sigma-Aldrich). The paraffin sections were treated with xylene and a series of ethanol solutions. Subsequently, antigen retrieval was conducted using 0.1% trypsin at 37˚C for 5 min, and the sections were incubated with 3% H 2 O 2 for 15 min. The sections were then incubated with the antibody in a humid chamber at 4˚C for 24 h, prior to incubation with fluorescein isothionate (FITC) or tetramethyl-rhodamine-isothiocyanate (TRITC)-conjugated rabbit anti-mouse IgG secondary antibodies (1:100; cat. no. YB-22908 and YB33709ES60, respectively; Shanghai Yubo Biotech Co., Ltd., Shanghai, China) at 37˚C for 1 h. The cell nuclei were visualized in the masseter and palatal tissues samples using 4',6-diamidino-2-phenylindole (DAPI; Molecular Probes, Thermo Fisher Scientific, Inc.). Fluorescence imaging was captured using a laser scanning confocal microscope (LSM710; Carl Zeiss AG, Oberkochen, Germany) or fluorescence microscope (Olympus BX61; Olympus Corporation) with an excitation wavelengths of 490 nm for FITC and 550 nm for TRITC. If the fluorescent signal areas (green) were consistent with the cell nuclei (blue) in the tissue samples stained with DAPI, the cells were determined to be BrdU-positive BMMCs.
M-cadherin is a member of the Ca 2+ -dependent cell-cell adhesion molecule family, and its expression is confined to muscle satellite cells (19) . Elivision™ Plus kit (cat. no. KIT-9901) and Ultrasensitive™ S-P kit (cat. no. KIT-9709) (Fuzhou Maixin Biotechnology Co., Ltd., Fuzhou, China) were used to detect the expression of BrdU and M-cadherin (polyclonal rabbit anti-rat antibody; 1:100; cat. no. sc-10734; Santa Cruz Biotechnology, Inc., Dallas, TX, USA) in the masseter, in order to examine the distribution and myogenic orientation of the transplanted BMMCs. The blue/black BrdU-positive sections were visualized with 5-bromo-4-chloro-3-indolyl-phosphate (BCIP)/nitro-blue-tetrazolium, whereas the red/brown M-cadherin-positive sections were visualized with 3-amino-9-ethylcarbozole (AEC). The sections were counterstained with hematoxylin prior to being mounted.
The expression of osteocalcin by osteoblasts indicates the commencement of active bone formation (20) . Double immunohistochemical staining for osteocalcin (polyclonal rabbit anti-rat antibody; 1:100; cat. no. BA0121-2; Wuhan Boster Biological Technology, Ltd., Wuhan, China) and BrdU were performed to investigate the osteogenic differentiation of the transplanted BMMCs in the palatal bone. The blue/black BrdU-positive sections were visualized with BCIP/nitro-blue-tetrazolium, whereas the red/brown osteocalcin-positive sections were visualized with AEC.
Results
Changes of morphology following midpalatal expansion and BMMC transplantation in rats. H&E staining was performed to observe the morphological changes of the midpalatal bone in the groups of rats. A palatal shelf structure with an incision in the middle of the suture is shown in Fig. 1A . The midpalatal suture was centrally located, and the hyaline cartilage was separated. The chondrocytes on either side of the suture gradually matured and migrated laterally towards the bone-marrow-like cavities and the compact bone of the maxilla. The bony plates were enveloped by two layers of soft tissue, mucosa at the nasal and oral sides. In the submucosa tissue on the oral side, the palatine vessels and nerves formed (Fig. 1B) , the midpalatal suture was almost bridged by a large number of mononuclear cells. The chondrocytes remained evident and were involved in endochondral-type bone formation. By contrast, 4 weeks following BMMC transplantation in the EtR group (Fig. 1C) , the suture and surrounding tissues had already constituted newly formed bone, with a calcified compact structure and several small vessels. In the Exp group, 2 weeks following expansion (Fig. 1D) , endogenous spindle mesenchymal cells had migrated along the disconnected surface at the midline of the midpalatal suture. The chondrocytes were located laterally as mesenchymal cells, migrating into the incision ends and bridging one third of the incision. Following mechanical stimulation, the trabecular bone lining cells developed ultrastructural features of differentiated osteoblasts, and exhibited a cuboidal shape and rounded nuclei (Fig. 1E) . By contrast, the majority of the chondrocytes in the EaT group disappeared and were replaced by fibrous-like tissues, which contained numerous mesenchymal cells migrating from the submucosal tissue (Fig. 1F) . The submucosal layer became thicker, and numerous mesenchymal cells entered the surrounding compact palatal bone, which was transformed into trabecular bone (Fig. 1G) .
Tracking and observation of the expression of M-cadherin of transplanted BMMCs in the masseter.
During the 4 week experimental period, the BMMCs injected into the masseter were observed at several anatomical locations, traced by BrdU-positive staining. A number of positive spindle cells were located on the collagen fibers surrounding the blood vessels between the muscle fibers in the EaT group ( Fig. 2A and B) . During the experiment, a number of transplanted BMMCs penetrated into the blood vessels and exhibited rounded morphology in the EtR group (Fig. 2C) . Co-expression of BrdU and M-cadherin was observed, which appeared in the sublaminar position, usually occupied by satellite cells (Fig. 2D , EaT group; Fig. 2E , EtR group). However, no BrdU-positive cells were observed in the Exp group (Fig. 2F) . The observations demonstrated that the connective tissue fibers provided anchors In the Exp group, no cell channels were observed, however, (F) a row of cubic oseoblasts arrayed orderly at the boundary were observed between the neuromuscular bundle and the midpalatal bone. Scale bar=20 µm. BrdU, bromodeoxyuridine; BMMC, bone marrow mononuclear cells; Exp, expansion group; EaT, expansion and transplantation group; ExR, expansion and relapse group; EtR, expansion/transplantation/relapse group.
Tracking BMMCs in the midpalatal bone. Heterologous BMMC transplantation via masseter injection resulted in a large quantity of spindle cells migrating into the midpalatal bone injured by incision and expansion (Fig. 3) . These cells included, not only transplanted BMMCs, but also endogenous mesenchymal-like cells. In the EaT group, BrdU-positive cells were located in the fibrous-like tissue at the midline of the suture (Fig. 3A) , whereas they resided in the blood vessel walls (Fig. 3B) in the EtR group. In addition, mesenchymal-like cells in the ExR group were involved in midpalatal bone remodeling (Fig. 3C) . The junction between the soft and hard tissue manifested the importance of the differentiation of mesenchymal-like cells into osteoblasts. In the EaT group, BrdU-positive cells were also located in the bone-marrow-like tissues (Fig.3D) . The results clearly showed that the transplanted BMMCs, which appeared in the oral mucosa, enveloped the midpalatal bone in the EaT group (Fig. 3E) , and these differentiated into osteoblasts at the boundary of the neuromuscular bundle and in the newly forming bone during midpalatal bone regeneration (Fig. 3F) .
Expression of osteocalcin in BMMCs transplanted through the masseter into the midpalatal bone.
During midpalatal expansion in the BMMC transplantation (EaT) group, fibrous-like tissue channels formed from the submucosal tissues at the nasal side in the midpalatal bone. These channels contained a small number of clones of transplanted BMMCs, which appeared as blue/black BrdU-positive sections, and also contained a large number of spindle cells that originated from the host soft tissues. Several spindle cells expressing osteocalcin were indicated by a red/brown signal in these progenitor migrating channels (Fig. 4A) . Similar transplanted cells were observed in the submucosal tissue at the oral sides, which exhibited a darkened color indicating expression of osteocalcin, and a small number of transplanted BMMCs were located in the vessel walls in the EaT group (Fig. 4B, arrows) . After 4 weeks, a few transplanted BMMCs were located in the midpalatal bone in the EtR group, which exhibited a light red/brown color, indicating lower expression levels of osteocalcin (Fig. 4C) . In this group, a small number of BMMCs continued to co-express BrdU and osteocalcin, and were present at the junction of the mucosa and the midpalatal bone, as well as the vessels in the midpalatal bone (Fig. 4D) . Although mesenchyma-like cells, migrating from the submucosa at the nasal side, were also observed, no cell channels were observed in the Exp group (Fig. 4E ).
Chondroblasts were located along the mesial incision of the midpalatal bone, and a row of cubic oseoblasts were arrayed orderly at the boundary between the neuromuscular bundle and midpalatal bone in the Exp group (Fig. 4F) . A similar observation was observed in the BMMC transplantation group.
Discussion
Healing from injury requires the activation and proliferation of stem cells for tissue repair (21) . In the present study, a rat model exhibiting midpalatal incision and expansion was used to observe the trajectory of BMMCs following BMMC transplantation via masseter injection. The BMMCs injected into the masseter were observed, not only in the masseter, but also in the blood vessels and oral mucosa, and enveloped the midpalatal bone. A number of the BMMCs differentiated into osteoblasts at the boundary of the neuromuscular bundle, and were located in the newly formed bone during midpalatal bone regeneration. Rapid midpalatal expansion is a common treatment solution for patients with a narrow maxillary dental arch (22) . The results of previous studies have revealed the mechanism of midpalatal bone remodeling induced by mechanical expansion. Hall et al (23) reported that the re-establishment of a suture with the palatine bone margins was covered by newly formed cartilage in the oral side of a mice model. It has also been suggested that mesenchymal cells located on the inner side of the cartilaginous tissue proliferate and differentiate into osteoblasts when the suture is expanded (20, 24) . The midpalatal expansion model used in the present study differed from the above-mentioned studies, as a surgical incision was made in the suture to simulate the repair mechanism of distraction osteogenesis.
Several studies have demonstrated that stem cell transplantation has a marked effect on promoting callus formation and in shortening the consolidation period (25, 26) . The results of the present study demonstrated that, in the expansion groups, a natural healing process occurred, in which mesenchymal progenitors in the surrounding soft tissues migrated into the injured midpalatal bone and repaired the damaged bone by differentiating into chondroblasts and osteoblasts. BMMC transplantation accelerated midpalatal bone formation by increasing the number of mesenchymal stem cells, which differentiated into osteoblasts directly. Previous studies have suggested that transplanted BMMCs induce bone regeneration by enhancing the migration of host stem cells into injury sites in an endocrine manner (5, 27, 28) . These regenerative cells migrate from the surrounding soft tissues and replace the endochondral bone formation with intramembranous bone formation, possibly due blood supply being increased (29) , resulting in a microenvironment that favored stem cell differentiation into osteoblasts, rather than chondroblasts, due to the augmentation in oxygen content (30, 31) . These observations indicate the critical effect of microenvironmental cues on cell fate. However, tissues with non-specific stem cells may become more tissue-specific under the effect of environmental factors (32) . Multipotent stem cells exist in all tissues and have the ability to migrate among tissues in response to certain chemical signals. The mobilization patterns of stem cells may follow the laws of 'near to distant' and 'concentrated to diluted' in relation to various chemokines.
The regeneration consequence is a result of the combination of donor and endogenous stem cell migration to the injured midpalatal bone, either through osteogenic differentiation directly or through the production of cytokines (33, 34) . In the present study, BMMC transplantation via masseter injection presents a potential dynamic process to repair injured midpalatal bone. A number of the transplanted BMMCs appeared to be located in the sub-laminar position, usually occupied by satellite cells. In addition, certain transplanted BMMCs anchored and migrated along the collagenic fibers over large distances. These results are concordant with those of Laird et al (35) who demonstrated that the interstitial migration or active amoeboid movement of stem cells are induced by extravascular cues, and this migration occurs independently of blood flow. Frimberger et al (36) reported rapid motility of hematopoietic stem cells, directed migration to stromal cells and marked membrane modulation. In the present study, a number of the transplanted BMMCs transformed into vessel pericytes and had the ability to enter into the circulation, acquiring systemic characteristics. Following maxilla incision and stimulation by mechanical expansion, the stem cells were mobilized and migrated to the enveloped soft tissue of the midpalatal bone. The capillary wall and the membrane surrounding the vascular bundles served as delivery sites for the donor cells and other sources of host stem cells to reconstruct the midpalatal bone. These results suggested that BMMCs mobilized other host stem cells, which contributed to the replenishment of osteoblasts for regeneration of the injured bone.
Further investigation into the mechanisms underlying the migration of stem cells from surrounding tissues or the circulation during injury healing and diseases are required to develop alternative novel therapies. In inflamed regions, mesenchymal stem cells rapidly exit the blood by integrating into the endothelium and migrating through the endothelial barrier, prior to penetrating the basement membrane and invading the surrounding tissue (37) . Tumor formation has been suggested to be the result of continuously healing wound (38) . Experimental and clinical studies have revealed that bone marrow-derived progenitor cells can migrate into the circulation, incorporate into tumor microenvironments and contribute to the growth of various tumors (33, 39) . Chemotactic cytokines released by the damaged tissues mobilize progenitor cells by establishing mechanisms from the bone marrow, which may also regulate the mobilization of tissue-specific stem cells via other signaling pathways (40) . Undifferentiated tumor cells may enter the circulation and result in distant solid tumor formation when the balance of a stem cell niche in various tissues is disrupted. This suggests that malignant tumor formation may be a type of systemic disease, which exhausts all the stem cells that maintain the physiological activities and restorative capacity of organisms. Therefore, it may prove useful to use chemical cytokines, which mobilize repair cells throughout the whole body, as targets for treating malignant tumors (41, 42) .
In conclusion, the results of the present study demonstrated that BMMCs were able to enter the circulation, migrate from the muscle to bone tissue and were subsequently involved in tissue injury healing. These stem cells may be useful in the treatment of several types of cancer due to stem cell mobilization in the whole body.
